Prevention of Disease Progression with Anti-Inflammatory Therapy in Patients with HCV-Related Cirrhosis: A Markov Model

Publisher： Karger

E-ISSN： 1423-0232|86|5-6|295-302

ISSN： 0030-2414

Source： Oncology, Vol.86, Iss.5-6, 2014-06, pp. : 295-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 180-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Interferon Maintenance Therapy Improves Survival in Patients with HCV-Related Hepatocellular Carcinoma after Curative Radiofrequency Ablation

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 132-138

Karger

Access to resources Recommend Favorite

Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct‐acting anti‐virals

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 866-876

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 441-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease

By Alexander L. Pukhalsky   Galina V. Shmarina   Nikolai I. Kapranov   Svetlana N. Kokarovtseva   Daria Pukhalskaya   Natalia J. Kashirskaja  

Mediators of Inflammation, Vol. 13, Iss. 2, 2004-04 ,pp. : 111-117

Informa Healthcare

Access to resources Recommend Favorite